Viewing Study NCT04640402


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2025-12-26 @ 3:01 AM
Study NCT ID: NCT04640402
Status: COMPLETED
Last Update Posted: 2022-06-01
First Post: 2020-11-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module